Key facts
- This page summarizes Iris Acquisition Holdings LLC's Form 3 filing for Liminatus Pharma, Inc. (LIMN).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 15 Aug 2025, 14:50.
Iris Acquisition Holdings LLC - 30 Apr 2025 Form 3 Insider Report for Liminatus Pharma, Inc. (LIMN)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- LIMN
- Reported as of
- 30 Apr 2025
- Net transaction value
- $0
- Reporting owner signature
- Sumit Mehta, Authorized Representative
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Iris Acquisition Holdings LLC filed Form 3 for Liminatus Pharma, Inc. (LIMN) on 15 Aug 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002064461
Primary reporting owner
Iris Acquisition Holdings LLC
- Relationship
- 10%+ Owner
- Address
- 3RD FLOOR ZEPHYR HOUSE, 122 MARY STREET, P.O. BOX 10085, GEORGE TOWN, CAYMAN ISLANDS
- Signature
- Sumit Mehta, Authorized Representative
- Signature date
- 15 Aug 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LIMN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,900,000
- Date
- 30 Apr 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.